Regeneron Pharmaceuticals (REGN)
$706.94
16.53 (2.28%)
REGN Stock Quote Delayed 30 Minutes
7 Biotech Stocks to Buy and Hold in 2020
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
64.88B
PE Ratio
18.44
EPS
38.33
Volume (Avg. Vol.)
713,051
Day's Range
$701.07 - $721.41
52-Week Range
$642.00 - $1,211.20
Dividend & Yield
N/A (N/A)
REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News
Stock Market Today: Coronavirus Sparks 1,000-Point Dow Fall
At one point, the Dow Jones slid 1,000 and the Nasdaq was down more than 4% thanks to the coronavirus. Here's the stock market today.
4 Top Stock Trades for Tuesday: SPY, QQQ, MSFT, REGN
The SPY and QQQ were our focus, while Microsoft and Regeneron were our other top stock trades for Tuesday.
3 Big Stock Charts for Thursday: Kraft Heinz, Wabtec, and Regeneron Pharmaceuticals
Thursday's big stock charts detail the hopes for 3 stocks trying to recover from multi-year lows.
Regeneron Pharmaceuticals Earnings: REGN Stock Rockets 7% on Q3 Beat
Regeneron Pharmaceuticals (REGN) earnings for the biotechnology company's third quarter of 2019 have REGN stock soaring on Tuesday.
Why This Just Might Be the Biggest Week for CARA Stock
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
This Medical Device Company is Outperforming the Rest of the Sector
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.
Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss
Regeneron Pharmaceuticals earnings for the first quarter of 2019 have REGN stock falling on Tuesday due to poor results for the period.
This Is Why You Shouldn’t Count Regeneron Stock Out
When drug companies fall out of favor, as now, I look first to companies with a method for drug discovery like Regeneron stock.
